Healthcare solutions company Evolent Health (NYSE:EVH) fell short of the market’s revenue expectations in Q4 CY2024, but ...

Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results tomorrow after market close. Here’s what to ...

Citizens JMP raised the firm’s price target on Evolent Health (EVH) to $13 from $12 and keeps an Outperform rating on the shares. Evolent’s Q4 ...

Evolent Health, Inc. ( NYSE: EVH) Q4 2024 Earnings Conference Call February 20, 2025 5:00 PM ET Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Officer John Johnson - ...

Discover key insights from Evolent Health's Q4 2024 earnings call, focusing on 30% revenue growth, contract renegotiations, projections for 2025, ...

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Evolent Health (EVH – Research Report) today and set a price target of ...

For the current quarter ending in March, Evolent Health said it expects revenue in the range of $440 million to $470 million. The company expects full-year revenue in the range of $2.06 billion to ...

NYSE EVH opened at $10.44 on Friday. Evolent Health has a one year low of $9.45 and a one year high of $35.00. The stock has a 50-day moving average of $10.75 and a 200 day moving average of $18. ...

Evolent Health Inc (EVH) reports robust revenue growth and strategic contract extensions, while navigating increased oncology ...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look ...